https://www.selleckchem.com/pr....oducts/Neratinib(HKI
Background COVID-19 pandemic required a marked re-allocation of healthcare resources, including at Breast Units. A patient-tailored program was developed to assess its efficacy regarding prevention of COVID-19 infection among patients with breast cancer undergoing surgery and healthcare workers (HCWs). Patients and methods From March 9th to April 9th 2020, 91 patients were selected for elective surgery by means of i) Pre-hospital screening aimed at avoiding hospitalization of symptomatic or suspicious COVID-19 patients, and i
Like
Comment
Share
